As of January 2025, Genovate Biotechnology has a market cap of $69.24M. This makes Genovate Biotechnology the world's 21628th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $84.79M | -4.70% |
2023 | $88.98M | -18.15% |
2022 | $108.71M | 31.05% |
2021 | $82.95M | -15.11% |
2020 | $97.73M | 21.34% |
2019 | $80.54M | -7.22% |
2018 | $86.81M | -16.74% |
2017 | $104.26M | -15.30% |
2016 | $123.09M | -40.44% |
2015 | $206.68M | -1.46% |
2014 | $209.74M | 77.91% |
2013 | $117.89M | -20.21% |
2012 | $147.75M | 379.97% |
2011 | $30.78M | 0.00% |
2010 | $30.78M | 0.00% |
2009 | $30.78M | 13.50% |
2008 | $27.12M | -33.74% |
2007 | $40.93M | - |